NIH-funded research Fellowship grant

Understanding how nerve injury affects retinal cells

Official title: Retinal Circuitry Response to Nerve Injury

Funded at Yale University · NIH-10937071 · Data updated 2026-11-12

This study is looking at how different types of nerve cells in the eye respond when they get injured, with the goal of finding ways to help these cells survive and heal, which could lead to new treatments for people experiencing vision loss from nerve damage.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 7, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$48,974
NIH project number5F31EY034776-02
Project IDNIH-10937071 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing vision loss due to optic nerve injuries or related conditions.

Less likely to help

Patients with vision loss not related to nerve injury or those with irreversible retinal damage may not benefit from this research.

What this research studies

This research investigates the response of retinal ganglion cells (RGCs) to nerve injury, specifically focusing on how different types of RGCs survive or die following an optic nerve crush. By examining the electrical activity and cellular mechanisms involved, the study aims to identify ways to promote the survival and regeneration of these crucial cells, which are essential for vision. The approach includes using a surgical model to simulate nerve injury and analyzing the resulting changes in cellular behavior and signaling pathways. Patients may benefit from insights gained that could lead to new treatments for vision loss due to nerve damage.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that restore vision by promoting the survival and regeneration of retinal cells after injury.

How similar studies have gone: Previous research has shown promise in understanding retinal cell responses to injury, but this specific approach to enhancing RGC survival and regeneration is still being explored.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Zapadka, Thomas Eugene — Yale University
  • Study coordinator: Zapadka, Thomas Eugene

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.